drugset / Trial / NCT04621526

Monitored Anesthesia Care: Dexmedetomidine-Ketamine Versus Dexmedetomidine- Propofol For Chronic Subdural Hematoma

NCT04621526

Phase 1/2 Completed 56 enrolled Zagazig University
RandomizedParallel-groupDouble-blindTreatment

Summary

Inadequate sedation and analgesia indicated by intraoperative movements are markers of inadequate MAC during burr-hole surgery for chronic subdural hematoma evacuation especially when general anesthesia poses high risk for the patients. Dexmedetomidine, ketamine, propofol intravenous infusion and other agents was used to provide monitored anesthesia care with variable success if used as solitary agents as each drug has its limited use.

Timeline

Start
2020-11-10
Primary completion
2023-08-30
Completion
2023-08-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 0.5 mg/kg Intravenous
Comparator Propofol Small molecule 0.5 mg/kg Intravenous
Comparator Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous

Indications

No indication recorded.